Your browser doesn't support javascript.
loading
Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards.
Bottomley, Andrew; Pe, Madeline; Sloan, Jeff; Basch, Ethan; Bonnetain, Franck; Calvert, Melanie; Campbell, Alicyn; Cleeland, Charles; Cocks, Kim; Collette, Laurence; Dueck, Amylou C; Devlin, Nancy; Flechtner, Hans-Henning; Gotay, Carolyn; Greimel, Eva; Griebsch, Ingolf; Groenvold, Mogens; Hamel, Jean-Francois; King, Madeleine; Kluetz, Paul G; Koller, Michael; Malone, Daniel C; Martinelli, Francesca; Mitchell, Sandra A; Moinpour, Carol M; Musoro, Jammbe; O'Connor, Daniel; Oliver, Kathy; Piault-Louis, Elisabeth; Piccart, Martine; Pimentel, Francisco L; Quinten, Chantal; Reijneveld, Jaap C; Schürmann, Christoph; Smith, Ashley Wilder; Soltys, Katherine M; Taphoorn, Martin J B; Velikova, Galina; Coens, Corneel.
Afiliação
  • Bottomley A; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium. Electronic address: andrew.bottomley@eortc.be.
  • Pe M; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
  • Sloan J; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
  • Basch E; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, USA.
  • Bonnetain F; Methodology and Quality of Life Unit in Cancer, INSERM U1098, Universitary Hospital of Besançon, Besançon, France.
  • Calvert M; Centre for Patient Reported Outcomes Research, Institute of Applied Health Research, College of Medical and Dental Sciences, University of Birmingham, UK.
  • Campbell A; Genentech, a member of the Roche group, San Francisco, CA, USA.
  • Cleeland C; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Cocks K; Adelphi Values, Bollington, Cheshire, UK.
  • Collette L; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
  • Dueck AC; Alliance Statistics and Data Center, Mayo Clinic, Scottsdale, AZ, USA.
  • Devlin N; Office of Health Economics, London, UK.
  • Flechtner HH; Clinic for Child and Adolescent Psychiatry and Psychotherapy, University of Magdeburg, Magdeburg, Germany.
  • Gotay C; School of Population and Public Health, University of British Columbia, Vancouver, BC, Canada.
  • Greimel E; Obstetrics and Gynecology, Medical University Graz, Graz, Austria.
  • Griebsch I; Boehringer-Ingelheim, Frankfurt, Germany.
  • Groenvold M; Department of Public Health and Bispebjerg Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Hamel JF; Methodology and Biostatistics department, University Hospital of Angers UNAM, Angers, France.
  • King M; School of Psychology and Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
  • Kluetz PG; Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MA, USA.
  • Koller M; Center for Clinical Studies, University Hospital Regensburg, Regensburg, Germany.
  • Malone DC; College of Pharmacy, University of Arizona, Tucson, AZ, USA.
  • Martinelli F; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
  • Mitchell SA; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
  • Moinpour CM; Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  • Musoro J; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
  • O'Connor D; Medicines and Healthcare products Regulatory Agency, London, UK.
  • Oliver K; International Brain Tumour Alliance, Surrey, UK.
  • Piault-Louis E; Genentech, a member of the Roche group, San Francisco, CA, USA.
  • Piccart M; Internal Medicine/Oncology, Institut Jules Bordet, Brussels, Belgium.
  • Pimentel FL; Health Sciences, University of Aveiro, Aveiro, Portugal; Lenitudes Medical Center & Research, Santa Maria da Feira, Portugal.
  • Quinten C; European Centre for Disease Prevention and Control, Surveillance and Response Support Unit, Epidemiological Methods Section, Stockholm, Sweden.
  • Reijneveld JC; VU University Medical Center, Department of Neurology & Brain Tumor Center, Amsterdam, The Netherlands.
  • Schürmann C; Institute for Quality and Efficiency in Health Care, Cologne, Germany.
  • Smith AW; Outcomes Research Branch, Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
  • Soltys KM; Health Canada, Ottawa, ON, Canada.
  • Taphoorn MJB; Leiden University Medical Center/Medical Center Haaglanden, Leiden/The Hague, Netherlands.
  • Velikova G; Leeds Institute of Cancer and Pathology, University of Leeds, St James's Hospital, Leeds, UK.
  • Coens C; European Organisation for Research and Treatment of Cancer (EORTC Headquarters), Brussels, Belgium.
Lancet Oncol ; 17(11): e510-e514, 2016 Nov.
Article em En | MEDLINE | ID: mdl-27769798
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Ensaios Clínicos como Assunto / Medidas de Resultados Relatados pelo Paciente / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Ensaios Clínicos como Assunto / Medidas de Resultados Relatados pelo Paciente / Neoplasias Tipo de estudo: Clinical_trials / Guideline / Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2016 Tipo de documento: Article